Publication Date: June 2022
EBRC’s response to the request by HHS ASPR for comments on the Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides. EBRC convened a two-day workshop with stakeholders from academia, industry, and government to consider the Guidance, and the discussions that ensued formed the basis for this response.
Keywords: DNA synthesis; oligonucleotide screening; benchtop synthesis; security
Disclaimer: The following publications are intended for personal use. All persons reproducing, redistributing, or making commercial use of this information are expected to adhere to the terms and conditions as asserted by the copyright holder. Transmission or reproduction of protected items beyond that are allowed by fair use as defined in the copyright laws requires the written permission of the copyright owners.